000 | 01350 a2200421 4500 | ||
---|---|---|---|
005 | 20250513125258.0 | ||
264 | 0 | _c19971105 | |
008 | 199711s 0 0 eng d | ||
022 | _a0960-3271 | ||
024 | 7 |
_a10.1177/096032719701600906 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMartin, F | |
245 | 0 | 0 |
_aOrganotin compounds in trimethyltin-treated rats and in human brain in Alzheimer's disease. _h[electronic resource] |
260 |
_bHuman & experimental toxicology _cSep 1997 |
||
300 |
_a512-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAlzheimer Disease _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBrain _xmetabolism |
650 | 0 | 4 | _aChromatography, Gas |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIndicators and Reagents |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOrganotin Compounds _xanalysis |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aSpectrophotometry, Atomic |
650 | 0 | 4 |
_aTrimethyltin Compounds _xpharmacokinetics |
700 | 1 | _aCorrigan, F M | |
700 | 1 | _aDonard, O F | |
700 | 1 | _aKelly, J | |
700 | 1 | _aBesson, J A | |
700 | 1 | _aHorrobin, D F | |
773 | 0 |
_tHuman & experimental toxicology _gvol. 16 _gno. 9 _gp. 512-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/096032719701600906 _zAvailable from publisher's website |
999 |
_c9284305 _d9284305 |